Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bolger

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
Anticancer Research|March 8, 2019
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia CellsGordon T Bolger, Albert Licollari, Richard Bagshaw, et al.
Biochemical and Biophysical Research Communications|February 26, 1982
High affinity binding of a calcium channel antagonist to smooth and cardiac muscleG T Bolger, P J Gengo, E M Luchowski, et al.
Drug Development Research|August 19, 2021
Ketotifen is a Prodrug. Norketotifen is the active metaboliteAxel Karl Gunnar Aberg, Nada Arulnesan, Gordon T Bolger, et al.
Brain Research|March 19, 1986
Dihydropyridine calcium channel antagonists binding in non-mammalian vertebrates: characterization and relationship to 'peripheral-type' binding sites for benzodiazepinesG T Bolger, B A Weissman, H Lueddens, et al.
The American Journal of Cardiology|January 28, 2010
Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fractionS Morteza Farasat, Dennis T Bolger, Veena Shetty, et al.
Biochemical Pharmacology|January 15, 1988
Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sitesC R Mantione, M E Goldman, B Martin, et al.
ACS Applied Materials & Interfaces|August 4, 2012
Selective sidewall wetting of polymer blocks in hydrogen silsesquioxane directed self-assembly of PS-b-PDMSRichard G Hobbs, Richard A Farrell, Ciara T Bolger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1983
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscleG T Bolger, P Gengo, R Klockowski, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2018
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc<sup>™</sup>) in patients with locally advanced or metastatic cancerRichard Greil, Sigrun Greil-Ressler, Lukas Weiss, et al.
Nanotechnology|April 7, 2012
Mechanical constraint and release generates long, ordered horizontal pores in anodic alumina templatesCiara T Bolger, Giovanni Fois, Nikolay Petkov, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
Anticancer Research|March 8, 2019
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia CellsGordon T Bolger, Albert Licollari, Richard Bagshaw, et al.
Biochemical and Biophysical Research Communications|February 26, 1982
High affinity binding of a calcium channel antagonist to smooth and cardiac muscleG T Bolger, P J Gengo, E M Luchowski, et al.
Drug Development Research|August 19, 2021
Ketotifen is a Prodrug. Norketotifen is the active metaboliteAxel Karl Gunnar Aberg, Nada Arulnesan, Gordon T Bolger, et al.
Brain Research|March 19, 1986
Dihydropyridine calcium channel antagonists binding in non-mammalian vertebrates: characterization and relationship to 'peripheral-type' binding sites for benzodiazepinesG T Bolger, B A Weissman, H Lueddens, et al.
The American Journal of Cardiology|January 28, 2010
Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fractionS Morteza Farasat, Dennis T Bolger, Veena Shetty, et al.
Biochemical Pharmacology|January 15, 1988
Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sitesC R Mantione, M E Goldman, B Martin, et al.
ACS Applied Materials & Interfaces|August 4, 2012
Selective sidewall wetting of polymer blocks in hydrogen silsesquioxane directed self-assembly of PS-b-PDMSRichard G Hobbs, Richard A Farrell, Ciara T Bolger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1983
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscleG T Bolger, P Gengo, R Klockowski, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2018
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc<sup>™</sup>) in patients with locally advanced or metastatic cancerRichard Greil, Sigrun Greil-Ressler, Lukas Weiss, et al.
Nanotechnology|April 7, 2012
Mechanical constraint and release generates long, ordered horizontal pores in anodic alumina templatesCiara T Bolger, Giovanni Fois, Nikolay Petkov, et al.
Pageof 18